Bridgeway Capital Management, LLC Timber Pharmaceuticals, Inc. Transaction History

Bridgeway Capital Management, LLC

  • $4.44 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$0.38 - $0.89 $39,938 - $93,539
-105,100 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$1.06 - $2.25 $57,876 - $122,850
54,600 Added 108.12%
105,100 $128,000
Q1 2021

May 17, 2021
SELL
$0.81 - $3.55 $87,318 - $382,690
-107,800 Reduced 68.1%
50,500 $103,000
Q3 2020

Nov 16, 2020
BUY
$0.92 - $2.4 $145,636 - $379,920
158,300 New
158,300 $157,000

About Timber Pharmaceuticals, Inc.

TMBR Quotes by TradingView
  • Ticker TMBR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,524,992
  • Description
  • Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...
More about TMBR
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email